Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,261
-
Total 13F shares
-
2,464,547
-
Share change
-
+144,771
-
Total reported value
-
$55,596,000
-
Price per share
-
$22.51
-
Number of holders
-
42
-
Value change
-
+$3,050,178
-
Number of buys
-
24
-
Number of sells
-
17
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2015
As of 30 Sep 2015,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,464,547 shares.
The largest 10 holders included
MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, Advisors Asset Management, Inc., FIRST TRUST ADVISORS LP, UBS Group AG, LPL Financial LLC, CREDIT SUISSE AG/, LADENBURG THALMANN FINANCIAL SERVICES INC, and BANK OF AMERICA CORP /DE/.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.